Abstract P108: Impact of the Covid-19 Pandemic on Hyperacute Stroke Treatment: Experience From a Comprehensive Stroke Centre in Singapore
العنوان: | Abstract P108: Impact of the Covid-19 Pandemic on Hyperacute Stroke Treatment: Experience From a Comprehensive Stroke Centre in Singapore |
---|---|
المؤلفون: | Aftab Ahmad, Benjamin Yong-Qiang Tan, Amanda Chin, Prakash R Paliwal, Cunli Yang, Aloysius Sheng-Ting Leow, Vivek Sharma, Daniel Chor, Bernard P.L. Chan, Jennifer Hung, Ying-Wei Yau, Chang-Chuan Lee, Zhixuan Quak, Mingxue Jing, David K Tang, Magdalene Lj Chia, Ei T Zune, Hock-Luen Teoh, Christopher Yuan Kit Chua, Anil Gopinathan, Leonard L.L. Yeo, Raymond C.S. Seet, Gail Brenda Cross, Deborah Khoo, Sunny Sibi, Lily Y.H. Wong, Yihui Goh |
المصدر: | Stroke. 52 |
بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2021. |
سنة النشر: | 2021 |
مصطلحات موضوعية: | Advanced and Specialized Nursing, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), business.industry, medicine.medical_treatment, Outbreak, Emergency department, Thrombolysis, medicine.disease, Hyperacute stroke, Pandemic, Emergency medicine, Medicine, Neurology (clinical), Cardiology and Cardiovascular Medicine, business, Stroke, Cohort study |
الوصف: | Background: The Coronavirus disease 2019 (COVID-19) pandemic is rapidly evolving and affecting healthcare systems across the world. Singapore has escalated its alert level to Disease Outbreak Response System Condition (DORSCON) Orange, signifying severe disease with community spread. Objectives: We aimed to study the overall volume of AIS cases and the delivery of hyperacute stroke services during DORSCON Orange. Methods: This was a single-centre, observational cohort study performed at a comprehensive stroke centre responsible for AIS cases in the western region of Singapore, as well as providing care for COVID-19 patients. All AIS patients reviewed as an acute stroke activation in the Emergency Department (ED) from November 2019 to April 2020 were included. System processes timings, treatment and clinical outcome variables were collected. Results: We studied 350 AIS activation patients admitted through the ED, 206 (58.9%) pre- and 144 during DORSCON Orange. Across the study period, number of stroke activations showed significant decline (p =0.004, 95% CI 6.513 - -2.287), as the number of COVID-19 cases increased exponentially, whilst proportion of activations receiving acute recanalization therapy remained stable ( p = 0.519, 95% CI -1.605 - 2.702). Amongst AIS patients that received acute recanalization therapy, early neurological outcomes in terms of change in median NIHSS at 24 hours (-4 versus -4, p = 0.685) were largely similar between the pre- and during DORSCON orange periods. Conclusions: The number of stroke activations decreased while the proportion receiving acute recanalization therapy remained stable in the current COVID-19 pandemic in Singapore. |
تدمد: | 1524-4628 0039-2499 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::58108d4d566ad7006360a9519fcefb29 https://doi.org/10.1161/str.52.suppl_1.p108 |
رقم الأكسشن: | edsair.doi...........58108d4d566ad7006360a9519fcefb29 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15244628 00392499 |
---|